Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sanofi CEO Remains Positive on China and Other Emerging Markets

publication date: Oct 1, 2013
Sanofi is taking the “big picture” approach to emerging markets, according to its CEO, refusing to stop investing in developing countries because of pricing pressure and government crackdowns. In fact, Sanofi will continue to seek acquisitions in emerging markets, said Chris Viehbacher, Sanofi’s CEO, and it will presumably also forge partnerships, as it has done in China. There will be occasional setbacks, he continued, but the markets are too important to ignore. More details....

Stock Symbol: (NYSE: SNY)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital